Atrial Fibrillation Lifestyle Project

NCT03724383 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-10-30

No results posted yet for this study

Summary

The objectives of the investigators are to demonstrate a reduction in frequency and symptoms of AF and improvements in cardiovascular risk factors following a lifestyle intervention in patients with paroxysmal AF. Participants will be randomized into control or intervention groups. The intervention will receive step trackers, diet counselling, an exercise program, and risk factor modification consultations. Controls will receive step trackers and care as usual. Testing will occur at baseline, six months, and one year.

Conditions

  • Atrial Fibrillation Paroxysmal

Interventions

BEHAVIORAL

Risk Factor Management Consult

Participants may be referred to an Internist to control risk factor management - this may require monthly visits until risk factor targets have been met.

BEHAVIORAL

Diet Classes

Group nutrition sessions delivered two times per week (1 hr each), over a 3 month period (months 0 to 3 of intervention) delivered by a registered dietitian.

BEHAVIORAL

Stress Management Classes

Group sessions delivered two times per week (1 hr each), over a 3 month period (months 0 to 3 of intervention). Techniques taught will include awareness, coping, and relaxation strategies.

OTHER

Exercise Classes

Group sessions delivered two times per week (1 hr each), over 3 month period (months 3-6). Classes will include high intensity interval training, resistance training.

OTHER

Home based exercise program

The interval and resistance training program will mirror the supervised exercise.

Sponsors & Collaborators

  • Vancouver Coastal Health

    collaborator OTHER_GOV
  • Vancouver Coastal Health Research Institute

    collaborator OTHER
  • University of British Columbia

    collaborator OTHER
  • Teddi Orenstein Lyall

    lead OTHER

Principal Investigators

  • Teddi Orenstein Lyall, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-06
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03724383 on ClinicalTrials.gov